TY - JOUR T1 -门诊治疗继发性自发性气胸:随机对照试验JF -欧洲呼吸杂志》乔和J - 10.1183/13993003.03375 -2020欧元六世- 57 - 6 SP - 2003375 AU -沃克,Steven p . AU -基南艾玛盟——Bintcliffe奥利弗AU -斯坦顿,安德鲁·e . AU -罗伯茨,马克盟——Pepperell贾斯汀AU -费尔贝恩,伊恩AU -部,爱德华盟,一同James AU - Maddekar, Nadeem AU - Walters, James AU - West, Alex AU - Bhatta, Amrithraj AU - Knight, Matthew AU - Mercer, Rachel AU - halifax, Rob AU - White, Paul AU - Miller, Robert F. AU - Rahman, Najib M. AU - Maskell，Nick A. Y1 - 2011/06/01 UR - //www.qdcxjkg.com/content/57/6/2003375.abstract N2 -继发性自发性气胸(SSP)传统的治疗方法是将肋间胸腔导管与水下海豹相连。我们研究使用单向颤振阀是否缩短了患者的住院时间(LoS)。这项开放标签随机对照试验招募了使用SSP的患者，并随机选择使用胸管和水下密封(标准护理:SC)或使用颤振阀的门诊护理(AC)。使用的颤振阀的类型取决于患者是否在随机分组中已经有了胸膜管:在没有胸膜管的患者中，使用了胸腔通气管;在那些原位有胸管的患者中，附加心房压肺器(AP)瓣膜。主要终点是LoS。在2017年3月至2020年3月期间，41例患者接受了随机分组:20例为SC, 21例为AC (13=PV, 8=AP)。 There was no difference in LoS in the first 30 days following treatment intervention: AC (median=6 days, IQR 14.5) and SC (median=6 days, IQR 13.3). In patients treated with PV there was a high rate of early treatment failure (6/13; 46%), compared to patients receiving SC (3/20; 15%) (p=0.11) Patients treated with AP had no (0/8 0%) early treatment failures and a median LoS of 1.5 days (IQR 23.8).There was no difference in LoS between ambulatory and standard care. Pleural Vents had high rates of treatment failure and should not be used in SSP. Atrium Pneumostats are a safer alternative, with a trend towards lower LoS.Ambulatory management with a flutter valve does not shorten overall length of stay in patients with secondary spontaneous pneumothoraces compared to standard management. This was due to increased risk of treatment failure with ambulatory management. https://bit.ly/2JEd3YC ER -